Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent

Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace...

Continue Reading Regenlab is in Breach of UK Court Orders Following Revocation of its PRP Patent

5CC Aesthetics Conference – Barcelona, Spain – August 2019

Estar Medical is delighted to take part in the 5CC aesthetics conference and exhibition. One of the top lasers and aesthetic meetings in the world. You're welcome to visit our team in booth #58 and learn more about our new innovations in the PRP and autologous cell therapy fields...

Continue Reading 5CC Aesthetics Conference – Barcelona, Spain – August 2019

European Patent Office revoked Regenlab PRP patent

Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step...

Continue Reading European Patent Office revoked Regenlab PRP patent